PAA 0.00% 19.5¢ pharmaust limited

Ann: FDA Provides Clear Feedback for ODD Approval, page-8

  1. 11,748 Posts.
    lightbulb Created with Sketch. 5949
    The FDA never believe the hype . It's a refined process.
    First 45 days Vetting ,
    next was processing but no data , none , can't process the application without supportive data , pretty simple...

    Great that the FDA have said they will keep open the application ,, I would say we have 10 to 15 working days to supply the Phase I/ II MND Data and then a complete resubmission will be required,, because its a stack that is being worked through from Companies that have supplied the supportive information and the FDA will not penalise them by taking up time to process an application that is incomplete and void of Data... NZT

    The question is 'Why has the Phase I/II data taken so long to analyse" ?
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.77M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.